Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,077 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Arenavirus Induced CCL5 Expression Causes NK Cell-Mediated Melanoma Regression.
Bhat H, Zaun G, Hamdan TA, Lang J, Adomati T, Schmitz R, Friedrich SK, Bergerhausen M, Cham LB, Li F, Ali M, Zhou F, Khairnar V, Duhan V, Brandenburg T, Machlah YM, Schiller M, Berry A, Xu H, Vollmer J, Häussinger D, Thier B, Pandyra AA, Schadendorf D, Paschen A, Schuler M, Lang PA, Lang KS. Bhat H, et al. Among authors: schadendorf d. Front Immunol. 2020 Aug 21;11:1849. doi: 10.3389/fimmu.2020.01849. eCollection 2020. Front Immunol. 2020. PMID: 32973762 Free PMC article.
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.
Lakshmikanth T, Burke S, Ali TH, Kimpfler S, Ursini F, Ruggeri L, Capanni M, Umansky V, Paschen A, Sucker A, Pende D, Groh V, Biassoni R, Höglund P, Kato M, Shibuya K, Schadendorf D, Anichini A, Ferrone S, Velardi A, Kärre K, Shibuya A, Carbone E, Colucci F. Lakshmikanth T, et al. Among authors: schadendorf d. J Clin Invest. 2009 May;119(5):1251-63. doi: 10.1172/JCI36022. Epub 2009 Apr 6. J Clin Invest. 2009. PMID: 19349689 Free PMC article.
New developments in biomarkers for melanoma.
Griewank KG, Ugurel S, Schadendorf D, Paschen A. Griewank KG, et al. Among authors: schadendorf d. Curr Opin Oncol. 2013 Mar;25(2):145-51. doi: 10.1097/CCO.0b013e32835dafdf. Curr Opin Oncol. 2013. PMID: 23334230 Review.
Vemurafenib reverses immunosuppression by myeloid derived suppressor cells.
Schilling B, Sucker A, Griewank K, Zhao F, Weide B, Görgens A, Giebel B, Schadendorf D, Paschen A. Schilling B, et al. Among authors: schadendorf d. Int J Cancer. 2013 Oct 1;133(7):1653-63. doi: 10.1002/ijc.28168. Epub 2013 Apr 13. Int J Cancer. 2013. PMID: 23526263 Free article.
Genetic evolution of T-cell resistance in the course of melanoma progression.
Sucker A, Zhao F, Real B, Heeke C, Bielefeld N, Maβen S, Horn S, Moll I, Maltaner R, Horn PA, Schilling B, Sabbatino F, Lennerz V, Kloor M, Ferrone S, Schadendorf D, Falk CS, Griewank K, Paschen A. Sucker A, et al. Among authors: schadendorf d. Clin Cancer Res. 2014 Dec 15;20(24):6593-604. doi: 10.1158/1078-0432.CCR-14-0567. Epub 2014 Oct 7. Clin Cancer Res. 2014. PMID: 25294904 Free PMC article.
Analysis of SDHD promoter mutations in various types of melanoma.
Scholz SL, Horn S, Murali R, Möller I, Sucker A, Sondermann W, Stiller M, Schilling B, Livingstone E, Zimmer L, Reis H, Metz CH, Zeschnigk M, Paschen A, Steuhl KP, Schadendorf D, Westekemper H, Griewank KG. Scholz SL, et al. Among authors: schadendorf d. Oncotarget. 2015 Sep 22;6(28):25868-82. doi: 10.18632/oncotarget.4665. Oncotarget. 2015. PMID: 26327518 Free PMC article.
1,077 results